I am pleased to announce that Timothee Olivier from Geneva, Switzerland has agreed to be the new senior editor at the Drug Development Letter.
What this means is more regular content.
We are planning to discuss one of our favorite papers every Friday and will post more podcast discussions on new drugs. We are also open to suggestions. Email Timothee with ideas.
If you are curious what our discussions sound like; check out our latest on Ribociclib
If you support our work, subscribe
Finally learn more about Timothee here:
This is wonderful news! :)